QUANTERIX CORP (QTRX) Stock Price, Quote, News and Overview

Company Profile

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 441 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The firm's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. The company also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. The company has completed over 2,200 projects for 480 customers using its Simoa platforms.

Company Info

QUANTERIX CORP

900 Middlesex Turnpike

Billerica MASSACHUSETTS 01821 US

CEO: E. Kevin Hrusovsky

Employees: 441

Company Website: https://www.quanterix.com/

Investor Relations: https://ir.quanterix.com/

Phone: 16173019400